VISA-Daptomycin non-susceptible Staphylococcus aureus frequently demonstrate non-susceptibility to Telavancin

被引:2
|
作者
Saravolatz, Louis D. [1 ]
Pawlak, Joan [1 ]
机构
[1] Ascens St John Hosp, Detroit, MI 48236 USA
关键词
Telavancin; Daptomycin; CLSI; Staphylococcus aureus; Methicillin-resistant Staphylococcus aureus; BROTH MICRODILUTION METHOD; IN-VITRO ACTIVITY; COLLECTION; VANCOMYCIN;
D O I
10.1016/j.diagmicrobio.2018.09.003
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Telavancin was evaluated against S. aureus isolates with reduced susceptibility to other antimicrobial agents using two broth microdilution methods and Etest (R) strips. The three methods provided comparable results. Differences in telavancin susceptibility versus non-susceptibility were noted mainly in the VISA-daptomycin non-susceptible group of isolates. In this group the percent susceptibility was 38% for the Etest (R) method and 50% and 54% for the 2 broth microdilution methods. All differences in susceptibility were within one 2-fold dilution. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:159 / 161
页数:3
相关论文
共 50 条
  • [31] Mechanisms of in-vitro-selected daptomycin-non-susceptibility in Staphylococcus aureus
    Patel, Diixa
    Husain, Mashkur
    Vidaillac, Celine
    Steed, Molly E.
    Rybak, Michael J.
    Seo, Susan M.
    Kaatz, Glenn W.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2011, 38 (05) : 442 - 446
  • [32] Down-regulation of the two-component system and cell-wall biosynthesis-related genes was associated with the reversion to daptomycin susceptibility in daptomycin non-susceptible methicillin-resistant Staphylococcus aureus
    Iwata, Y.
    Satou, K.
    Tsuzuku, H.
    Furuichi, K.
    Senda, Y.
    Sakai-Takemori, Y.
    Wada, T.
    Fujita, S.
    Miyake, T.
    Yasuda, H.
    Sakai, N.
    Kitajima, S.
    Toyama, T.
    Shinozaki, Y.
    Sagara, A.
    Miyagawa, T.
    Hara, A.
    Shimizu, M.
    Kamikawa, Y.
    Kaneko, S.
    Wada, T.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2017, 36 (10) : 1839 - 1845
  • [33] Down-regulation of the two-component system and cell-wall biosynthesis-related genes was associated with the reversion to daptomycin susceptibility in daptomycin non-susceptible methicillin-resistant Staphylococcus aureus
    Y. Iwata
    K. Satou
    H. Tsuzuku
    K. Furuichi
    Y. Senda
    Y. Sakai-Takemori
    T. Wada
    S. Fujita
    T. Miyake
    H. Yasuda
    N. Sakai
    S. Kitajima
    T. Toyama
    Y. Shinozaki
    A. Sagara
    T. Miyagawa
    A. Hara
    M. Shimizu
    Y. Kamikawa
    S. Kaneko
    T. Wada
    European Journal of Clinical Microbiology & Infectious Diseases, 2017, 36 : 1839 - 1845
  • [34] Performance of vancomycin and teicoplanin disk diffusion test in isogenic vancomycin non-susceptible Staphylococcus aureus
    Wongthong, Sujintana
    Dutchanutouch, Karnjana
    Namsaengkang, Viladda
    Chanawong, Aroonwadee
    Wilailuckana, Chotechana
    Lulitanond, Aroonlug
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2015, 9 (02): : 157 - 164
  • [35] Successful treatment of a left ventricular assist device infection with daptomycin non-susceptible methicillin-resistant Staphylococcus aureus: case report and review of the literature
    Levy, D. T.
    Steed, M. E.
    Rybak, M. J.
    Guo, Y.
    Gialanella, P.
    Hanau, L.
    Muggia, V.
    Ostrowsky, B.
    TRANSPLANT INFECTIOUS DISEASE, 2012, 14 (05) : E89 - E96
  • [36] Comparative activity of the new lipoglycopeptide telavancin in the presence and absence of serum against 50 glycopeptide non-susceptible staphylococci and three vancomycin-resistant Staphylococcus aureus
    Leuthner, Kimberly D.
    Cheung, Chrissy M.
    Rybak, Michael J.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (02) : 338 - 343
  • [37] Multicenter evaluation of the etest and disk diffusion methods for differentiating daptomycin-susceptible from non-daptomycin-susceptible Staphylococcus aureus isolates
    Jevitt, Laura A.
    Thorne, Grace M.
    Traczewski, Maria M.
    Jones, Ronald N.
    McGowan, John E., Jr.
    Tenover, Fred C.
    Brown, Steven D.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (09) : 3098 - 3104
  • [39] Role of stop codons in development and loss of vancomycin non-susceptibility in methicillin-resistant Staphylococcus aureus
    Doddangoudar, V. C.
    O'Donoghue, M. M.
    Chong, E. Y. C.
    Tsang, D. N. C.
    Boost, M. V.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (09) : 2101 - 2106
  • [40] Characterization of an osteomyelitis case caused by dalbavancin, ceftaroline, and vancomycin non-susceptible methicillin-resistant Staphylococcus aureus
    Dahdouh, Elias
    Diaz-Pollan, Beatriz
    Falces-Romero, Iker
    Mingorance, Jesus
    Gomez-Gil, Rosa
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2021, 40 (09) : 2029 - 2032